2026年5月8日，归创通桥医疗科技股份有限公司（股票代码：02190）发布公告，披露其于香港联交所回购部分股份的相关信息。根据公告，公司于当日回购了50,000股H股，占回购前现有已发行股份约0.0149%，回购价格介乎每股21.62港元至22.48港元，总付出的金额约111.05万港元。
本次回购完成后，公司已发行股份数量由327,355,613股降至327,305,613股，库存股份增至9,045,131股，整体已发行股本总数维持在336,350,744股。公司购回授权于2025年5月30日获得通过，最多可回购31,958,111股；截至本次回购完成后，公司已累计回购6,225,500股，占购回授权通过当日已发行股份总数的约1.9022%。同时，根据公告，任何新股发行或库存股份出售的暂止期将持续至2026年6月7日。
公告显示，公司已严格遵守香港联合交易所有限公司证券上市规则及相关法律规定。公告由公司董事赵中签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.